Title: Goran K Hansson - Innovator in Cardiovascular Therapies
Introduction
Goran K Hansson is an inventor based in Stockholm, Sweden. He is known for his contributions to the field of cardiovascular therapies. Although he currently holds no granted patents, his innovative ideas are reflected in his latest patent applications.
Latest Patent Applications
One of Goran K Hansson's notable patent applications is for a therapy involving 3-hydroxyanthranilic acid (3-HAA) for the prevention and treatment of hyperlipidemia and its cardiovascular complications. This invention focuses on the use of a tryptophan metabolite to provide prophylactic and therapeutic treatment against various cardiovascular issues, including atheroma formation, myocardial infarction, and heart failure. Another significant application involves fusion proteins comprising antigenic apoB-100 protein fragments and a protein carrier, aimed at the treatment and prevention of atherosclerosis. This application highlights the potential of using a fusion protein with an antigenic fragment of apoB-100 for therapeutic purposes.
Conclusion
Goran K Hansson is an innovative inventor whose work in cardiovascular therapies shows promise for future advancements in medical treatments. His latest patent applications reflect a commitment to addressing critical health issues related to hyperlipidemia and atherosclerosis.